BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Sep 27, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

VBL Therapeutics preclinical data

In mice, once-daily 0.04 and 0.4 mg/kg doses of oral VB-201 for 5 days significantly delayed the onset of experimental autoimmune encephalomyelitis (EAE)...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >